Effects of a polyherbal formulation on the quality of life and survival of patients with common upper gastrointestinal cancers: A randomized placebo-controlled trial | ||
Avicenna Journal of Phytomedicine | ||
دوره 11، شماره 6، بهمن و اسفند 2021، صفحه 566-575 اصل مقاله (620.55 K) | ||
نوع مقاله: Original Research Article | ||
شناسه دیجیتال (DOI): 10.22038/ajp.2021.18132 | ||
نویسندگان | ||
Azar Fani Pakdel1؛ Ashkan Hatami1؛ Roham Salek1؛ Ali Taghizadeh-Kermani2؛ Seyed Alireza Javadinia3؛ Ahmad Ghorbani* 4 | ||
1Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran | ||
2Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran | ||
3Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran | ||
4Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran. Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran | ||
چکیده | ||
Objective: Previous clinical trials have suggested that herbal medicines can improve the quality of life (QOL) and survival of cancer patients. This study was aimed to evaluate the effects of a polyherbal compound (PHC, formulated as syrup) consisting of Allium sativum, Curcuma longa,Panax ginseng, and Camellia sinensis on the quality of life (QOL) and survival in patients with upper gastrointestinal cancers. Materials and Methods: A randomized placebo-controlled trial was carried out on patients with esophageal or gastric cancer who had finished their oncological treatments. The patients were randomly assigned to PHC (n=20) or placebo (n=20) group. The PHC group was treated with the PHC for 12 weeks, while the placebo group received 70% sucrose syrup. The QOL was assessed at baseline and after 12 weeks. The patients were followed for up to 24 months to determine overall survival. Results: PHC significantly improved cancer-related symptoms, physical performance, and psychological and social functions of the patients (p<0.05 for all cases). Death occurred in 33 and 22% of cases in the placebo and PHC group, respectively. The mean survival time was 16.8 months (95% CI: 12.8-20.9) in the placebo group and 21.4 months (95% CI: 19.1-23.6) in the PHC group but the difference was not statistically significant. Conclusion: The PHC improved cancer-related symptoms, physical performance, and psychological and social functions in patients with gastrointestinal cancers. It seems that this herbal compound has the potential to be used as a supplement in the management of cancer. | ||
کلیدواژهها | ||
Camellia sinensis؛ Cancer؛ Curcuma longa؛ Allium sativum؛ Panax ginseng؛ Quality of life | ||
مراجع | ||
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC. 1993. The European Organization for Research and Treatment of Cancer QLQ- Fani Pakdel et al. AJP, Vol. 11, No. 6, Nov-Dec 2021 574 C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85: 365-376. Alibeiki F, Jafari N, Karimi M, Dogaheh HP. 2017. Potent anti-cancer effects of less polar Curcumin analogues on gastric adenocarcinoma and esophageal squamous cell carcinoma cells. Sci Rep, 7: 2559. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. 2006. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res, 66: 1234-1240. Chung LY, Cheung TC, Kong SK, Fung KP, Choy YM, Chan ZY, Kwok TT. 2001. Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci, 68: 1207-1214. Cui Y, Shu X-O, Gao Y-T, Cai H, Tao M-H, Zheng W. 2006. Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol, 163: 645-653. Derogar M, Lagergren P. 2012. Health-related quality of life among 5-year survivors of esophageal cancer surgery: a prospective population-based study. J Clin Oncol, 30: 413-418. Erejuwa OO, Sulaiman SA, Wahab MSA. 2014. Effects of honey and its mechanisms of action on the development and progression of cancer. Molecules, 19: 2497- 2522. Fayers P, Aaronson NK, Bjordal K, Grønvold M, Curran D, Bottomley A. 2001. The EORTC QLQ-C30 scoring manual 3rd Edition edn. European Organisation for Research and Treatment of Cancer, Brussels. Ghorbani A, Mohebbati R, Jafarian AH, Vahedi MM, Hosseini SM, Soukhtanloo M, Sadeghnia HR. 2016. Toxicity evaluation of hydroalcoholic extract of Ferula gummosa root. Regul Toxicol Pharmacol, 77: 35-41. Gore GG, Satish S, Ganpule A, Srivastava S, and Athavale M. 2021. Garlic (Allium sativum) exhibits anticancer and anticancer stem cell activity on breast, prostate, colon, hepatic and cervical cancer cell lines. Int J Herbal Med, 9: 93-99. Hosseini A, Ghorbani A. 2015. Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomed, 5: 84-97. Hosseini A, Mollazadeh H, Amiri MS, Sadeghnia HR, Ghorbani A. 2017. Effects of a standardized extract of Rheum turkestanicum Janischew root on diabetic changes in the kidney, liver and heart of streptozotocin-induced diabetic rats. Biomed Pharmacother, 86: 605-611. Hwang IC, Yun YH, Kim Y-W, Ryu KW, Kim YA, Kim S, Bae J-M, Noh J-H, Sohn T-S. 2014. Factors related to clinically relevant fatigue in disease-free stomach cancer survivors and expectation–outcome consistency. Supportive Care Cancer, 22: 1453-1460. Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson AB, Mariotto A, Lake AJ, Wilson R, Sherman RL. 2017. Annual report to the nation on the status of cancer, 1975– 2014, featuring survival. J Natl Cancer Inst. 109: djx030. Jiao L, Bi L, Lu Y, Wang Q, Gong Y, Shi J, Xu L. 2018. Cancer chemoprevention and therapy using chinese herbal medicine. Biol Proced Online, 20: 1-14. Karanicolas PJ, Graham D, Gönen M, Strong VE, Brennan MF, Coit DG. 2013. Quality of life after gastrectomy for adenocarcinoma: a prospective cohort study. Ann Surg, 257: 1039-1046. Kim JH, Park CY, Lee SJ. 2006. Effects of Sun Ginseng on subjective quality of life in cancer patients: a double‐blind, placebo‐ controlled pilot trial. J Clin Pharm Ther, 31: 331-334. Korenaga D, Orita H, Okuyama T, Moriguchi S, Maehara Y, Sugimachi K. 1992. Quality of life after gastrectomy in patients with carcinoma of the stomach. Br J Surg, 79: 248-250. Lenartz D, Dott U, Menzel J, Schierholz J, Beuth J. 2000. Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. Anticancer Res, 20: 2073-2076. Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, Haji-Mahmoodi M. 1999. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version. Support Care in Cancer, 7: 400-406. Njei B, McCarty TR, Birk JW. 2016. Trends in esophageal cancer survival in United States Effects of a polyherbal formulation on gastrointestinal cancers AJP, Vol. 11, No. 6, Nov-Dec 2021 575 adults from 1973 to 2009: a SEER database analysis. J Gastroenterol Hepatol, 31: 1141- 1146. Numico G, Longo V, Courthod G, Silvestris N. 2015. Cancer survivorship: long-term sideeffects of anticancer treatments of gastrointestinal cancer. Curr Opin Oncol, 27: 351-357. Panahi Y, Saadat A, Beiraghdar F, Sahebkar A. 2014. Adjuvant therapy with bioavailability‐ boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double‐blind placebo‐controlled trial. Phytother Res, 28: 1461-1467. Piao B, Wang Y, Xie G, Mansmann U, Matthes H, Beuth J, Lin H. 2004. Impact of complementary mistletoe extract treatment on quality of Life in breast, ovarian and nonsmall cell lung cancer patients a prospective randomized controlled clinical trial. Anticancer Res, 24: 303-310, Saklani A, Kutty SK. 2008. Plant-derived compounds in clinical trials. Drug Discov Today, 13: 161-171. Singh V. 2017. Effect of application of honey in chemoradiation-induced mucositis and to assess its clinical benefits in improving quality of life in patients of head and neck cancer. Int J Oral Maxillofac Surg, 46: 248- 249. Strong VE, Wu Aw, Selby LV, Gonen M, Hsu M, Song KY, Park CH, Coit DG, Ji Jf, Brennan MF. 2015. Differences in gastric cancer survival between the US and China. J Surg Oncol, 112: 31-37. Suh SO, Kroh M, Kim NR, Joh YG, Cho MY. 2002. Effects of red ginseng upon postoperative immunity and survival in patients with stage III gastric cancer. Am J Chin Med, 30: 483-494. Tanaka S, Haruma K, Yoshihara M, Kajiyama G, Kira K, Amagase H, Chayama K. 2006. Aged garlic extract has potential suppressive effect on colorectal adenomas in humans. J Nutr, 136: 821S-826S. Tantoy IY, Cooper BA, Dhruva A, Cataldo J, Paul SM, Conley YP, Hammer M, Kober KM, Levine JD, Miaskowski C. 2018. Quality of life of patients with gastrointestinal cancers undergoing chemotherapy. Qual Life Res, 27: 1865- 1876. WHO. 2018. WHO key facts about cancer. Available from http://www.who.int/en/news-room/factsheets/detail/cancer [Accessed on 1 February 2018]. Zaid H, Silbermann M, Amash A, Gincel D, Abdel-Sattar E, Sarikahya NB. 2017. Medicinal plants and natural active compounds for cancer chemoprevention/chemotherapy. Evid Based Complement Alternat Med, 2017: 7952417. Zhu H, Liu H, Zhu JH, Wang SY, Zhou SS, Kong M, Mao Q, Long F, Fang ZJ, Li SL. 2021. Efficacy of ginseng and its ingredients as adjuvants to chemotherapy in non-small cell lung cancer. Food Funct, 12: 2225- 2241. | ||
آمار تعداد مشاهده مقاله: 17,875 تعداد دریافت فایل اصل مقاله: 718 |